[Use of partusisten in prevention of hyperkalemia in patients with chronic glomerulonephritis with initial forms of renal failure].
The studies performed proved the ability of the drug partusisten (in a dose of 10 mg/day) to effectively reduce an elevated potassium level in the serum of chronic sufferers with glomerulonephritis and initial renal insufficiency. Normal concentrations of Ca, K and Na in relevant patients remained unchanged except a slight rise in K urinary excretion this suggesting an extrarenal mechanism of K redistribution consequent to the action of beta 2-adrenergic agents.
Skinskiĭ
I M
IM
Komandenko
M S
MS
Shulutko
B I
BI
Zamoskovskaia
G A
GA
D000328:Adult; D002118:Calcium / Q000097:blood; D005260:Female; D005280:Fenoterol / Q000627:therapeutic use*; D005921:Glomerulonephritis / Q000378:metabolism*; D006801:Humans; D006947:Hyperkalemia / Q000209:etiology / Q000517:prevention & control*; D007676:Kidney Failure, Chronic / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D011188:Potassium / Q000097:blood / Q000652:urine; D012964:Sodium / Q000097:blood
D005280:Fenoterol; D012964:Sodium; D011188:Potassium; D002118:Calcium
Primenenie partusistena dlia borby s giperkaliemieĭ u bol'nykh khronicheskim glomerulonefritom s nachal'nymi formami pochechnoĭ nedostatochnosti.